D98. Targeting the Scar: Mechanisms and Treatments for Fibrotic Lung Disease 2022
DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5319
|View full text |Cite
|
Sign up to set email alerts
|

Sustained Improvement of Interstitial Lung Disease Following Enzyme Replacement Therapy with Olipudase Alfa in Children and Adults with Chronic Acid Sphingomyelinase Deficiency

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles